Notice 9 Jul 2025 compliance, healthcare, pennsylvania, drug enforcement, medical licensing, practitioner regulations

⚖️Revocation of DEA Registration and Business Compliance Implications

The Drug Enforcement Administration issued an Order to Show Cause against Dr. Hayriye Gok, proposing the revocation of her registration due to a suspended medical license in Pennsylvania. The document also lays out the procedural steps for enforcement and the consequences of defaulting on requests for hearings.

Learn More
Notice 9 Jul 2025 compliance, healthcare, regulation, new mexico, dea, drug enforcement, physician assistant

💊DEA Revokes Registration of Practitioner John Hanley, P.A.

The Drug Enforcement Administration has issued an Order to Show Cause proposing the revocation of John Hanley, P.A.'s registration, citing lack of authority to handle controlled substances in New Mexico due to the revocation of his physician assistant license. The Agency finds Registrant's default and confirms the necessity of state licensing for DEA registration, ruling the revocation effective immediately.

Learn More
Notice 8 Jul 2025 compliance, healthcare, medical license, dea, drug enforcement, state regulation, physician

⚖️DEA Revokes Physician's Registration

The Drug Enforcement Administration has issued a decision revoking the DEA registration of Dr. William Washington due to his lack of authority to practice medicine in Washington State. The order emphasizes the requirement for physicians to maintain state licensing to handle controlled substances, impacting compliance standards within the healthcare sector.

Learn More
Notice 8 Jul 2025 regulatory compliance, healthcare, dea, drug enforcement, illinois, nursing

🚫DEA Revocation of Nurse Practitioner’s Registration

The Drug Enforcement Administration issued an Order to Show Cause proposing the revocation of Tanya Newlove's registration for handling controlled substances due to the expiration of her state nursing licenses. The agency highlights the critical requirement for practitioners to maintain valid state authority to dispense controlled substances, indicating significant compliance issues.

Learn More
Notice 7 Jul 2025 compliance, healthcare, ohio, dea, drug enforcement, medical regulation

⚖️DEA Revokes Registration of Dr. Loretta Clement - Key Outcomes

The Drug Enforcement Administration has revoked Dr. Loretta Clement's registration to prescribe and handle controlled substances due to her inactive medical license in Ohio. This action underscores the imperative for medical professionals to maintain proper state licensing to operate legally under federal law, reflecting ongoing regulatory enforcement in the healthcare sector.

Learn More
Notice 7 Jul 2025 regulation, business compliance, chemical industry, dea, drug enforcement

🏭Proposed Information Collection Under Chemical Diversion Control Act

The Department of Justice (DOJ), Drug Enforcement Administration (DEA), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.

Learn More
Notice 7 Jul 2025 regulatory compliance, business operations, chemical manufacturing, dea, drug enforcement

🧪Annual Reporting Requirements for Chemical Manufacturers by DEA

The Department of Justice (DOJ), Drug Enforcement Administration (DEA), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.

Learn More
Notice 7 Jul 2025 regulatory compliance, dea, drug enforcement, business registration, narcotic treatment

💊DEA Notice on Narcotic Treatment Program Registration Requirements

The Department of Justice (DOJ), Drug Enforcement Administration (DEA), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.

Learn More
Proposed Rule 26 Jun 2025 compliance, healthcare, regulation, administrative practice and procedure, reporting and recordkeeping requirements, drug traffic control, drug enforcement, opioids

⚖️Temporary Scheduling of Benzimidazole-Opioids for Public Safety

The Acting Administrator of the Drug Enforcement Administration is issuing this notice of intent to publish a temporary order to schedule seven benzimidazole-opioid substances in schedule I of the Controlled Substances Act. When it is finalized, the temporary scheduling order will impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess) or propose to handle these seven specified substances.

Learn More
Notice 26 Jun 2025 regulatory compliance, healthcare, california, dea, drug enforcement, medical licensing

🚫DEA Revokes Registration of Dr. Bohdan Olesnicky

The Drug Enforcement Administration has revoked the DEA registration of Dr. Bohdan Olesnicky due to his lack of authority to practice medicine in California, following his voluntary surrender of his medical license. This action highlights the necessity for healthcare professionals to maintain state licensure to manage controlled substances legally under federal law.

Learn More